CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metastatic...
Phase 1
Houston, Texas, United States
administered in combination with peginterferon alfa-2b to pediatric patients with unresectable Stage III, metastatic, or recurrent cutaneous melanoma...
Phase 2
Houston, Texas, United States and 2 other locations
ATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph ...
Phase 2
Houston, Texas, United States and 9 other locations
ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma...
Phase 2
Houston, Texas, United States and 9 other locations
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
Houston, Texas, United States and 70 other locations
binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...
Phase 3
Houston, Texas, United States and 227 other locations
and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + tram...
Phase 3
Houston, Texas, United States and 10 other locations
cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of...
Phase 1, Phase 2
Houston, Texas, United States and 20 other locations
You are being asked to take part in this study because you have advanced melanoma.The goal of this clinical research study is to learn if or...
Phase 2
Houston, Texas, United States
tolerability, PK and antitumor activities of IN10018 as monotherapy and in combination with cobimetinib in subjects with metastatic uveal melanoma...
Phase 1
Houston, Texas, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal